Correction to: Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors (Acta Neuropathologica, (2024), 148, 1, (68), 10.1007/s00401-024-02836-5)

Jotanovic, Jelena (57329668900)Jelena (57329668900)JotanovicBoldt, Henning Bünsow (7004515504)Henning Bünsow (7004515504)BoldtBurton, Mark (55532338400)Mark (55532338400)BurtonAndersen, Marianne Skovsager (7403194727)Marianne Skovsager (7403194727)AndersenBengtsson, Daniel (53879501800)Daniel (53879501800)BengtssonBontell, Thomas Olsson (57212027997)Thomas Olsson (57212027997)BontellEkman, Bertil (7003927285)Bertil (7003927285)EkmanEngström, Britt Edén (7005863207)Britt Edén (7005863207)EngströmFeldt-Rasmussen, Ulla (7005437081)Ulla (7005437081)Feldt-RasmussenHeck, Ansgar (54684013300)Ansgar (54684013300)HeckJakovcevic, Antonia (38461187500)Antonia (38461187500)JakovcevicJørgensen, Jens Otto L. (8081653500)Jens Otto L. (8081653500)JørgensenKraljevic, Ivana (14321919600)Ivana (14321919600)KraljevicKunicki, Jacek (7005533934)Jacek (7005533934)KunickiLindsay, John R. (7201433530)John R. (7201433530)LindsayLosa, Marco (7006017626)Marco (7006017626)LosaLoughrey, Paul Benjamin (56993777000)Paul Benjamin (56993777000)LoughreyMaiter, Dominique (7005343694)Dominique (7005343694)MaiterMaksymowicz, Maria (16448279000)Maria (16448279000)MaksymowiczManojlovic-Gacic, Emilija (36439877900)Emilija (36439877900)Manojlovic-GacicPahnke, Jens (16417489700)Jens (16417489700)PahnkePetersenn, Stephan (6604085672)Stephan (6604085672)PetersennPetersson, Maria (7006073800)Maria (7006073800)PeterssonPopovic, Vera (35451450900)Vera (35451450900)PopovicRagnarsson, Oskar (54884610400)Oskar (54884610400)RagnarssonRasmussen, Åse Krogh (7102424093)Åse Krogh (7102424093)RasmussenReisz, Zita (57188956223)Zita (57188956223)ReiszSaeger, Wolfgang (26649622700)Wolfgang (26649622700)SaegerSchalin-Jäntti, Camilla (6701824881)Camilla (6701824881)Schalin-JänttiScheie, David (6507605065)David (6507605065)ScheieTerreni, Maria Rosa (7005964976)Maria Rosa (7005964976)TerreniTynninen, Olli (6602467732)Olli (6602467732)TynninenWhitelaw, Ben (12241622100)Ben (12241622100)WhitelawBurman, Pia (7004519451)Pia (7004519451)BurmanCasar-Borota, Olivera (54411899300)Olivera (54411899300)Casar-Borota2025-06-122025-06-122025https://doi.org/10.1007/s00401-024-02838-3https://www.scopus.com/inward/record.uri?eid=2-s2.0-85214473080&doi=10.1007%2fs00401-024-02838-3&partnerID=40&md5=b18fa9f51a7c22a04a073af953df8657https://remedy.med.bg.ac.rs/handle/123456789/543In the original publication of this article, upper and lower part of Table 2 was incorrectly formatted. The incorrect and correct version of Table 2 are shown in this correction article. The original article has been corrected. Relevant significantly enriched gene sets associated with the DMPs that differed between aggressive and metastatic PitNETs in the first surgery specimens (upper table) and in the entire cohort (lower table) Hypermethylated and positive enriched in PC pval padj NES size KEGG cell adhesion molecules CAMS 6.26E-07 5.63E-05 1.65 122 KEGG axon guidance 6.51E-07 5.63E-05 1.65 122 KEGG pathways in cancer 1.43E-06 8.24E-05 1.44 313 KEGG neuroactive ligand receptor interaction 6.39E-06 0.00028 1.44 249 KEGG focal adhesion 7.16E-05 0.0015 1.44 191 KEGG adherens junction 8.97E-05 0.0017 1.64 67 KEGG calcium signaling pathway 0.00025 0.0039 1.40 166 KEGG leukocyte transendothelial migration 0.0019 0.019 1.43 108 KEGG ECM receptor interaction 0.0019 0.019 1.49 83 KEGG gap junction 0.0063 0.036 1.40 83 KEGG axon guidance 1.60E-06 0.00028 1.53 122 KEGG calcium signaling pathway 3.22E-06 0.00028 1.44 166 KEGG neuroactive ligand receptor interaction 0.00010 0.0045 1.31 249 KEGG regulation of actin cytoskeleton 0.00013 0.0045 1.34 197 KEGG MAPK signaling pathway 0.00030 0.0066 1.29 251 KEGG cell adhesion molecules cams 0.0018 0.035 1.33 122 KEGG ECM receptor interaction 0.0034 0.049 1.36 83 KEGG Wnt signaling pathway 0.0052 0.064 1.27 145 KEGG Hedgehog signaling pathway 0.0057 0.064 1.40 55 KEGG leukocyte transendothelial migration 0.011 0.10 1.28 108 Relevant significantly enriched gene sets associated with the DMPs that differed between aggressive and metastatic PitNETs in the first surgery specimens (upper part of the table) and in the entire cohort (lower part of the table) Hypermethylated and positive enriched in PC pval padj NES size KEGG Cell adhesion molecules CAMS 6.26E-07 5.63E-05 1.65 122 KEGG Axon guidance 6.51E-07 5.63E-05 1.65 122 KEGG Pathways in cancer 1.43E-06 8.24E-05 1.44 313 KEGG Neuroactive ligand receptor interaction 6.39E-06 0.00028 1.44 249 KEGG Focal adhesion 7.16E-05 0.0015 1.44 191 KEGG Adherens junction 8.97E-05 0.0017 1.64 67 KEGG Calcium signaling pathway 0.00025 0.0039 1.40 166 KEGG Leukocyte transendothelial migration 0.0019 0.019 1.43 108 KEGG ECM receptor interaction 0.0019 0.019 1.49 83 KEGG Gap junction 0.0063 0.036 1.40 83 Hypermethylated and positive enriched in PC pval padj NES size KEGG Axon guidance 1.60E-06 0.00028 1.53 122 KEGG Calcium signaling pathway 3.22E-06 0.00028 1.44 166 KEGG Neuroactive ligand receptor interaction 0.00010 0.0045 1.31 249 KEGG Regulation of actin cytoskeleton 0.00013 0.0045 1.34 197 KEGG MAPK signaling pathway 0.00030 0.0066 1.29 251 KEGG Cell adhesion molecules cams 0.0018 0.035 1.33 122 KEGG ECM receptor interaction 0.0034 0.049 1.36 83 KEGG Wnt signaling pathway 0.0052 0.064 1.27 145 KEGG Hedgehog signaling pathway 0.0057 0.064 1.40 55 KEGG Leukocyte transendothelial migration 0.011 0.10 1.28 108 © The Author(s) 2024.Correction to: Genome-wide methylation profiling differentiates benign from aggressive and metastatic pituitary neuroendocrine tumors (Acta Neuropathologica, (2024), 148, 1, (68), 10.1007/s00401-024-02836-5)